PhiKan 083
PhiKan 083 is a carbazole derivative, which binds to the surface cavity and stabilizes Y220C (a p53 mutant), with a Kd of 167 μM. PhiKan 083 can be used for cancer research[1].
Product Specifications
CAS Number
880813-36-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PhiKan_083.html
Purity
98.93
Solubility
DMSO : 100 mg/mL (ultrasonic) |Ethanol : 100 mg/mL (ultrasonic)
Smiles
CNCC1=CC2=C(C=C1)N(CC)C3=C2C=CC=C3
Molecular Formula
C16H18N2
Molecular Weight
238.33
Precautions
H302, H315, H319, H335
References & Citations
[1]Boeckler FM, et al. Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proc Natl Acad Sci U S A. 2008 Jul 29;105 (30) :10360-5.|[2]Rauf SM, et al. Effect of Y220C mutation on p53 and its rescue mechanism: a computer chemistry approach. Protein J. 2013 Jan;32 (1) :68-74.|[3]Paulmurugan R, et al. A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells. Oncotarget. 2018 Apr 20;9 (30) :21495-21511.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KN418653 1 Kit
Putative uncharacterized protein LOC388820 (LOC388820) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC941038-500 1x 500 µL
CD45RA (111-1C5), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
